| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Diabetes > The Obesity Epidemic and Juvenile Diabetes |
|
Advice Pool - The Obesity Epidemic and Juvenile Diabetes
The increasing obesity epidemic among children today is thought to be a leading cause in the increase in juvenile diabetes in this country today. Whi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product le not everyone agrees on the causes and affects it is hard to argue with the continuing increase of children with Type 2 diabetes who are also overw ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ight. In fact as the percentages of obese children raises so does the percentage of those affected with juvenile diabetes at nearly the same rate. T lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ere appear to be two main reasons for this increase in Type 2 diabetes among children. Most children these days have a sedentary lifestyle that revol here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe es around watching TV, playing video games, or using their computer to chat with and email their friends. The second issue for many kids is their poo d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro eating habits and nutrition. Living the fast food life style or eating a bag a chips while playing video games is one of the major reasons for the p ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc eponderance of overweight kids we see today. For many years Type 2 diabetes was something that overweight adults had to contend with, mainly because easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi children weren't having the weight issues they have today. Type 2 diabetes in an adult is also known as non-insulin-dependent diabetes. The primary t nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically eatment for this type of this disease is lifestyle changes involving diet and exercise for both children and adults. One of the main concerns with t and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ pe 2 juvenile diabetes is the affects it can have later on in a child's life. Children with type 2 diabetes have been found to have more life threate ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ing complications than type 1 diabetics. Some of the major problems juveniles with this type of diabetes face include heart disease, damage to the ne ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a vous system, renal failure, blindness, and limb amputations, particularly of the feet and lower legs. The first line of defense against juvenile typ dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod 2 diabetes is probably the most obvious. Maintain a healthy body weight through proper diet and exercise thus preventing the onset of the disease. F cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin r children already diagnosed this same treatment applies if they are to avoid the complications to their health later in life. For the juvenile diab tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen tic a healthy diet is the cornerstone of their treatment. A well balanced diet low in sugar, saturated fats, and salt is the way to go. High fiber fo t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ds such as fruits and vegetables, along with complex carbohydrates are best for the diabetic. Even then foods high in carbs should be eaten throughou ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust the day to help prevent large rises in blood glucose levels. Regular physical activity or exercise is also recommended to help insulin move glucose y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ut of the blood and into the cells. Childhood obesity is an epidemic all parents should take seriously. The long term health affects of all children . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de are at stake, particularly with an increased risk of juvenile diabetes, a disease that will affect any child for their life time. By making easy life elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tyle changes centered on a healthy diet and physical activity the onset of type 2 diabetes can be prevented, or even delayed in children at high risk tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Innovation Management - The Need For Knowledge Managers A Date That Will Last in Infamy
|